www.fdanews.com/articles/152006-watson-seeks-approval-of-generic-version-of-cancer-drug-velcade

Watson Seeks Approval of Generic Version of Cancer Drug Velcade

January 1, 2013

Watson Pharmaceuticals said it has applied for U.S. approval to market a generic version of Velcade (bortezomib), a treatment for multiple myeloma made by Takeda Pharmaceutical.
Reuters